Novartis (NVS)
(Delayed Data from NYSE)
$113.95 USD
+0.18 (0.16%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $114.45 +0.50 (0.44%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Novartis (NVS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$123.20 | $130.00 | $116.00 | 8.29% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Novartis comes to $123.20. The forecasts range from a low of $116.00 to a high of $130.00. The average price target represents an increase of 8.29% from the last closing price of $113.77.
Analyst Price Targets (5 )
Broker Rating
Novartis currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 2.86 a month ago based on 14 recommendations.
Of the 12 recommendations deriving the current ABR, one is Strong Buy, representing 8.33% of all recommendations. A month ago, Strong Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 10 | 11 | 11 | 9 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.00 | 3.00 | 2.86 | 2.57 | 2.54 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/30/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
9/5/2024 | Goldman Sachs | James Quigley | Strong Buy | Hold |
9/3/2024 | Not Identified | Not Identified | Strong Buy | Hold |
7/2/2024 | Berenberg Bank | Kerry Holford | Hold | Hold |
4/24/2024 | BMO Capital Markets | Etzer Darout | Hold | Hold |
4/23/2024 | Not Identified | Not Identified | Hold | Hold |
4/1/2024 | Cowen & Co. | Steve M Scala | Hold | Hold |
1/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/2/2024 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 12 |
Average Target Price | $123.20 |
LT Growth Rate | 8.90% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 47 of 252 |
Current Quarter EPS Est: | 1.93 |
NVS FAQs
Novartis AG (NVS) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for Novartis AG (NVS) is $123.20. The current on short-term price targets is based on 6 reports.
The forecasts for Novartis AG (NVS) range from a low of $116 to a high of $130. The average price target represents a increase of $8.12 from the last closing price of $113.95.
The current UPSIDE for Novartis AG (NVS) is 8.12%
Based on short-term price targets offered by five analysts, the average price target for Novartis comes to $123.20. The forecasts range from a low of $116.00 to a high of $130.00. The average price target represents an increase of 8.29% from the last closing price of $113.77.